跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
CUTAQUIG 3.3g/20mL Human Normal Immunoglobulin 16.5% solution for subcutaneous injection vial - TGA Drug Approval Details
Approvals
/
TGA
/
CUTAQUIG 3.3g/20mL Human Normal Immunoglobulin 16.5% solution for subcutaneous injection vial
Approved
STANDARD
CUTAQUIG 3.3g/20mL Human Normal Immunoglobulin 16.5% solution for subcutaneous injection vial
Octapharma Australia Pty Ltd
🇦🇺 Therapeutic Goods Administration
Approval Date
May 29, 2025
Approval ID
313caa2b9045dbbb
Company
Octapharma Australia Pty Ltd
Type
Standard
Approval Details
Approval Id
313caa2b9045dbbb
Product Name
CUTAQUIG 3.3g/20mL Human Normal Immunoglobulin 16.5% solution for subcutaneous injection vial
Artg Id
333121
Artg Name
CUTAQUIG 3.3g/20mL Human Normal Immunoglobulin 16.5% solution for subcutaneous injection vial
Sponsor
Octapharma Australia Pty Ltd
Artg Date
2021-05-03
Registration Type
Medicine
Therapeutic Good Type
Medicine
Licence Status
A
Licence Category
RE
Active Ingredients
Approved
Quick Info
Agency
TGA
Country
🇦🇺
Approval Date
May 29, 2025
Approval ID
313caa2b9045dbbb
Type
Standard
Back to TGA Approvals